Advertisement

Topics

A (Slight) Liberalization of Communications with Docs from FDA

06:41 EDT 14 Jun 2018 | Eye on FDA

What Happened. This week FDA issued a new final guidance related to communications about medical products that, while representing a slight liberalization of regulation when it comes to discussing useful information about a drug and the cleared uses for it, … Continue reading

Original Article: A (Slight) Liberalization of Communications with Docs from FDA

NEXT ARTICLE

More From BioPortfolio on "A (Slight) Liberalization of Communications with Docs from FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...